- Q2 2024 Coloplast A/S Earnings Call TranscriptMay 07, 2024kr842.4 (-3.46%)Earnings
- Q1 2024 Coloplast A/S Earnings Call TranscriptFeb 09, 2024kr891 (+9.70%)Earnings
- Q4 2023 Coloplast A/S Earnings Call TranscriptNov 09, 2023kr718 (-6.87%)Earnings
- Coloplast A/S to Discuss Complete Acquisition of Kerecis Call TranscriptSep 04, 2023
- Q3 2023 Coloplast A/S Earnings Call TranscriptAug 17, 2023kr801.6 (-2.65%)Earnings
- Coloplast A/S Announces Agreement to Acquire Kerecis Call TranscriptJul 07, 2023
- Q2 2023 Coloplast A/S Earnings Call TranscriptMay 11, 2023kr932.6 (-4.27%)Earnings
- Q1 2023 Coloplast A/S Earnings Call TranscriptFeb 03, 2023kr844.2 (-1.70%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 01, 2022
- Q4 2022 Coloplast A/S Earnings Call TranscriptNov 07, 2022kr792 (-2.10%)Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 31, 2022
- Q3 2022 Coloplast A/S Earnings Call TranscriptAug 17, 2022kr888.8 (+7.27%)Earnings
- Q2 2022 Coloplast A/S Earnings Call TranscriptMay 05, 2022kr950 (-5.52%)Earnings
- Coloplast A/S Virtual ESG Event Call TranscriptMar 22, 2022
- Q1 2022 Coloplast A/S Earnings Call TranscriptJan 25, 2022kr947 (+0.81%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 02, 2021
- Coloplast A/S to Acquire Atos Medical Call TranscriptNov 08, 2021
- Q4 2021 Coloplast A/S Earnings Call TranscriptNov 01, 2021kr1031.5 (-1.67%)Earnings
- Q3 2021 Coloplast A/S Earnings Call TranscriptAug 18, 2021kr1107.5 (-2.68%)Earnings
- Q2 2021 Coloplast A/S Earnings Call TranscriptMay 06, 2021kr970.6 (-5.58%)Earnings
- Q1 2021 Coloplast A/S Earnings Call TranscriptFeb 02, 2021kr1018 (+8.83%)Earnings
- Coloplast A/S at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q4 2020 Coloplast A/S Earnings Call TranscriptNov 03, 2020kr914.4 (-2.93%)Earnings
- Coloplast A/S Virtual Sustainability Deep-Dive Session TranscriptOct 09, 2020
- Coloplast A/S Virtual Deep-Dive Sessions TranscriptOct 07, 2020
- Coloplast A/S Virtual Capital Markets Day TranscriptSep 29, 2020
- Q3 2020 Coloplast A/S Earnings Call TranscriptAug 18, 2020kr997.6 (-3.85%)Earnings
- Coloplast A/S at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q2 2020 Coloplast A/S Earnings Call TranscriptMay 06, 2020kr1045 (-1.97%)Earnings
- Coloplast A/S Revised Full Year Organic Growth and EBIT Margin Guidance for 2019/2020 Call TranscriptMar 19, 2020
- Q1 2020 Coloplast A/S Earnings Call TranscriptFeb 06, 2020kr916.8 (+4.78%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 05, 2019
- Q4 2019 Coloplast A/S Earnings Call TranscriptNov 05, 2019kr794.6 (-3.89%)Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 20, 2019
- Q3 2019 Coloplast A/S Earnings Call TranscriptAug 14, 2019kr804 (+1.90%)Earnings
- Q2 2019 Coloplast A/S Earnings Call TranscriptMay 02, 2019kr705 (-1.48%)Earnings
Q3 2022 Coloplast A/S Earnings Call Transcript
Welcome to the Coloplast interim financial statements for 9M 2021, '22. (Operator Instructions)
With that, I'll hand the floor to our speakers. Please begin your meeting.
/-&
Good afternoon, and welcome to our Q3 '21/'22 Conference Call. My name Kristian Villumsen. I'm the CEO of Coloplast. And I'm joined by our CFO, Anders Lonning-Skovgaard; and our Investor Relations team. We'll start like we usually do with a short presentation by Anders and myself, and then open up for questions from you.
Please turn to Slide #3. In Q3, we delivered 8% organic growth and an EBIT margin before special items of 30%. We delivered a respectable return on invested capital of 26% after tax and before special items, impacted by the acquisition of Atos Medical. Reported growth in Danish kroner was 21%. Atos Medical contributed 9 percentage points to the reported growth and delivered double-digit underlying growth.
Before I dive into today's results, I'd
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)